ARCHIVES

In a letter, ASCO reaffirms its views on oncology consolidation at FDA.

This article is from The Cancer Letter archive.

Vol. 30 No. 28 | July 9, 2004

Download PDF Visit The Full Archive

Related Articles

FDA Oncologic Drugs Advisory Committee Okays THC For Group C List

July 4, 1980

ACS Research Budget Over $82 Million

July 17, 1987

Collins Sworn In As NIH Director

September 4, 2009

Amgen Says It Can Demonstrate Safety of Existing Hg Target.

March 16, 2007

NCCS Networker Volume 10 Issue 3, Winter 1996

January 13, 1996

Modality Combo Decreases Prostate Cancer Recurrence

August 27, 2004